JKJashwanth Raj Jagadeesh Kumar

Jashwanth Raj Jagadeesh Kumar

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jashwanth Raj Jagadeesh Kumar has a total of 6 co-authors. Here are the top co-authors by number of shared publications:

  • Agnishwar Girigoswami

    Medical Bionanotechnology, Faculty of Allied Health Sciences, Chettinad Hospital & Research Institute (CHRI), Chettinad Academy of Research and Education (CARE), Kelambakkam, Chennai, TN-603103, India

    1 shared publication
  • Devadass Jessy Mercy

    Faculty of Allied Health Sciences, Chettinad Hospital and Research Institute, Chettinad Academy of Research and Education, Chettinad Health City, Kelambakkam 603103, India

    1 shared publication
  • Jayaprakash Suresh

    Medical Bionanotechnology, Faculty of Allied Health Sciences, Chettinad Hospital and Research Institute, Chettinad Academy of Research and Education, Chettinad Health City, Kelambakkam, Chennai 603103, India

    1 shared publication
  • Koyeli Girigoswami

    Medical Bionanotechnology Laboratory, Department of Obstetrics and Gynaecology, Saveetha Medical College and Hospital, Saveetha Institute of Medical and Technical Sciences, Thandalam, Chennai 602105, India

    1 shared publication
  • Saranya Udayakumar

    Medical Bionanotechnology Lab, Department of Obstetrics and Gynecology, Saveetha Medical College and Hospital, Saveetha Institute of Medical and Technical Sciences, Thandalam, Chennai, India

    1 shared publication
  • Shangavy Pandiarajan

    Faculty of Allied Health Sciences, Chettinad Hospital and Research Institute, Chettinad Academy of Research and Education, Chettinad Health City, Kelambakkam 603103, India

    1 shared publication

Latest Publications

  • Open Access

    Revolutionizing Cancer Vaccine: The Power of Advanced Nanotechnology

    by Saranya Udayakumar, Shangavy Pandiarajan, Devadass Jessy Mercy, Jayaprakash Suresh, Jashwanth Raj Jagadeesh Kumar, Agnishwar Girigoswami, Koyeli Girigoswami

    Developing an effective vaccine that is safer is the main focus in the field of cancer immunotherapy. Among other therapeutic approaches, cancer nanovaccination is formulated to deliver tumor adjuvant or antigen to the antigen-presenting cells (APCs) to prevent cancer relapse and metastasis. It has shown excellent efficacy in inhibiting cancer growth. Herein, we discussed various forms of nanovaccines, including lipid-based nanovaccines, metal-based nanovaccines, carbon nanotube-based nanovaccines, PLGA-based nanovaccines, exosome-based nanovaccines, dendritic cell-based nanovaccines, and self-adjuvant nanovaccines in cancer immunotherapy, including their therapeutic effect. We expect that the investigated content will provide a valuable reference for future research and the development of nanovaccines for cancer treatment.